통도산(通導散)이 실험동물(實驗動物)의 심혈관계(心血管系)에 미치는 영향(影響)

Effects of Tongdosan on the Cardiovascular System in the Experimental Animals

  • 이인 (원광대학교 한의과대학 내과학교실) ;
  • 신선호 (원광대학교 한의과대학 내과학교실) ;
  • 문병순 (원광대학교 한의과대학 내과학교실)
  • Lee, In (Dept. of Internal Medicine College of Oriental Medicine Wonkwang University) ;
  • Shin, Sun-Ho (Dept. of Internal Medicine College of Oriental Medicine Wonkwang University) ;
  • Moon, Byung-Soon (Dept. of Internal Medicine College of Oriental Medicine Wonkwang University)
  • 발행 : 1996.03.30

초록

The present experiment was desinged to investigate the effects of Tongdosan water extracts on the Cardiovascular System in the Experimental Animals. Thus, the changes of blood pressure and heart rate were measured after oral admini- stration. Measurment of Mortality rate was observed for measuring the effect of Tongdosan water extract. Tongdosan water extract against pulmonary thrombo- embolism induced by collagen the mixture(0.1ml/10g, 2mg/kg B.W) plus serotonin(5mg/kg B.W) in mouse. The effect of Tongdosan water extract was examined by observing the change of collagen-induced platelet aggregation, coagulation activity, ex vivo and in vitro fibrinolytic activity of euglobulin fraction in rats. The results were summarized as followings. 1. Tongdosan dropped the blood pressure in spontaneous hypertensive rat. 2. The drug increased the auricular blood flow in rabbit. 3. The drug relaxed the artery contraction by pretreated norepinephrine in rat. 4. The drug inhibited the death rate of mouse which was led to thromboembo- lism by serotonin and collagen. 5. The drug inhibited the platelet aggregation in rat. 6. The drug prolonged the prothrombin time and activated partial thromboplastin time on the test of plasma coagulation factor activity in rat, but was not valuable. 7. The drug reduced the fibrinogen lyses time of rat ex vivo assay and lyses area was increased. 8. Tongdosan reduced fibrinogen lyses time of rat in vitro assay. According to the above mentioned results, Tongdosan increased the blood flow and dropped the blood pressure by the dilation of blood vessel. And the drug presented the antithrombin acivity, inhibited the platelet aggregation.

키워드

참고문헌

  1. 萬病回春 공廷賢
  2. 山東中醫藥學報 v.18 no.5 腦出血的中醫治療近況 金매(외)
  3. 東醫寶鑑 許浚
  4. 簡明方劑辭典 江克明;包明蕙
  5. 內科學(上冊) 上海中醫學院
  6. 東醫心系內科學 全國韓醫科大學心系內科學敎室(編)
  7. 中國醫學百科全書 中醫內科學 黃文東
  8. 中醫內科辨證學 王顯明
  9. 中醫臨床大全 楊思澍
  10. 中醫內科學 上海中醫學院
  11. 上海中醫藥 v.11 活血化瘀治療中風280例 李尉生
  12. 實用中西醫結合雜誌 v.6 no.12 活血化瘀法治療中風槪況 康德晃
  13. 山東中醫雜誌 v.13 no.10 血瘀證的硏究 王昌恩(외)
  14. 新中醫 v.27 no.4 活血化瘀法在臨床的應用 司徒志堅
  15. 天眞處方解說 成輔社(編)
  16. 臨床本草學 辛民敎
  17. 中草藥學 上海中醫學院
  18. 韓藥臨床應用 李尙仁(외)
  19. 申氏本草學 申佶求
  20. 中醫方劑與治法 陳潮朝(외)
  21. 中醫方劑選講 中山醫藥院
  22. 浙江中醫學院學報 v.18 no.3 論中風治須通降 陶亦鳴
  23. 日本一貫堂醫學紹介 v.123 醫林 編輯部
  24. 日本一貫堂醫學紹介 v.126 醫林 編輯部
  25. 日本一貫堂醫學紹介 v.130 醫林 編輯部
  26. 漢方一貫堂醫學 矢數格
  27. 慶熙韓醫大論文集 v.7 疏風活血湯이 血栓症에 미치는 影響 兪企英
  28. 大韓東醫病理學會誌 v.2 血府逐瘀湯이 血栓症과 皮下出血에 미치는 影響 崔昇勳
  29. 大韓東醫病理學會誌 v.4 Endotoxin으로 誘發된 白鼠의 血栓症에 身痛逐瘀湯이 미치는 影響 金東秀(외)
  30. 大韓東醫病理學會誌 v.4 復元活血湯이 Endotoxin으로 誘發된 白鼠의 血栓症에 미치는 影響 朴文秀(외)
  31. 圓光大學校 大學院 碩士學位論文 丹參飮이 實驗動物의 心血管系에 미치는 影響 申善浩
  32. 93年 韓國人死亡原因 統計 統計廳
  33. 中醫內科學 上海中醫學院
  34. 中風條辨 張茂珍
  35. 劉河間三六書 劉完素
  36. 東垣十種醫書 李東垣
  37. 丹溪心法 朱丹溪
  38. 景岳全書 張景岳
  39. 臨證指南醫案 葉天士
  40. 醫林改錯 王淸任
  41. 大田大學校 論文集(韓醫學篇) v.1 no.1 中風誘發과 血液流變에 關한 考察 趙鐘權(외)
  42. 大韓韓醫學會誌 v.11 no.1 中風의 血瘀論的 考察 및 活血化瘀法에 依한 治療 近況 崔賢(외)
  43. 中醫學基礎 上海中醫學院
  44. 中醫雜誌 v.28 no.6 冠心病血瘀證的硏究進展 翁維良
  45. 雲南中醫雜誌 v.13 no.1 活血化瘀法及其配伍在治療心血管疾病中的應用 黑衛可
  46. 黃帝內經素間譯解 楊維傑(編)
  47. 雲南中醫雜誌 v.15 no.2 瘀血證中醫基本理論硏究探析(續) 吳敏(외)
  48. 中醫內科學 南京中醫學院
  49. J. Pharma. Soc. Korea v.19 chemistry and pharmacology of diterpenoids of Siegesbeckia pubescens Han, K.D.;Kim, J.H.;Oh, S.J.
  50. Shoyakugaku Zasshi v.39 Inhibition of metyrapone and heatstress induced hypertension by Phellodendti Cortex Kuzuo, A.;Yasuo, O.;Chol, Jong-C.
  51. 日藥理誌 v.82 Eclatoninの抗高血壓作用に對す硏究 高柳法康(외)
  52. 부산대논문집 v.18 상기생의 순환기계 약리학적 연구 洪承喆
  53. 藥理學實驗法 田村風幸
  54. 藥效の評價(I) 津田恭介;野上壽
  55. J. Pharm. Pharmacol. v.21 A perfused tail artery preperation from the rat Nicholas, T.E.
  56. J. Phamacol. Exp. Therap. v.225 Mouse antithrombotic assay : A simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by alcohol Dimino, G.;Silver, M.J.
  57. Pharmacology and Toxicology v.70 Antithrombotci activity of a new pyrazosine derivative determined by the mouse antithrom-botic assay Petrusewiez, J.(et al.)
  58. Throm. Res. v.54 Role of free radicals in pulmonary thromboembolism in mice Dikshit, M.(et al.)
  59. Life Science v.51 A novel insight into the mechanism of the antithrombotic action of defibrotide Rosella, T.(et al.)
  60. Thrombosis and Hemostasis v.66 no.4 Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models Hara, H.(et al.)
  61. Tromb. Res. v.52 Comparison of hirudin and hirudin PA C-terminal fragments and related analogs as antithrombin agents Krstenansky, J.L.;Mao, S.J.T.
  62. Prostaglandins v.32 Effect of prostaglandins and arachidonic acid on baboon cerebral and mesenteric arteries Hayashi, S.;Park, M.K.
  63. Eur. J. Phamacol. v.81 Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog Lumley, P.(et al.)
  64. Thrombosis and Hemostasis Antithrombotic activity of a novel C-Terminal hirudin analog in experimental animals Broersma, R.J.(et al.)
  65. J. Phsiol v.168 the aggregation of blood platelets Born, G.C.R.;Cross, M.J.
  66. Thrombosis Res. v.65 TFC-612, a prostaglandin E1 derivative, enhance fibrolytic activity in rats Motoyama, Yukio(et al.)
  67. Tromb. Hemostasis v.47 Effect of prostacyclin on fibrolytic activity in patients with arteriosclerosis obliterans Kiek, A.D.;Trabka, E.K.(et al.)
  68. Tromb. Haemostasis v.46 The effect of prostacyclin infusion on tissue plasminogen activator Winther, K.(et al.)
  69. Angiology v.35 The role of fibrinolysis in the therapy of peripheral vascular disease Ambrus, C.N.(et al.)